Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 1.26 is 263% above its 4-year average of -0.77, near the high end of its 4-year range (-3.57–1.26).
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-07-04): 0.19.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 12 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T13:20:51.290Z. Historical observations retain their original dates. Historical series through 2026-10-05.
EARNINGS PER SHARE (EPS)
1.26
EARNINGS PER SHARE (EPS) AVG TTM
N/A
EARNINGS PER SHARE (EPS) AVG 3Y
0.11
EARNINGS PER SHARE (EPS) AVG 5Y
-0.77
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
+1034.11%
CURRENT VS 5Y AVG
+262.93%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Aveanna Healthcare Holdings Inc.
Market Cap
$2.69B
Earnings Per Share (EPS)
1.26
TTM Avg
N/A
3Y Avg
0.11
5Y Avg
-0.77
Market Cap
$2.69B
Earnings Per Share (EPS)
-12.45
TTM Avg
-4.69
3Y Avg
-1.64
5Y Avg
-2.01
Market Cap
$2.64B
Earnings Per Share (EPS)
N/A
TTM Avg
-0.45
3Y Avg
-0.45
5Y Avg
-0.45
Market Cap
$2.64B
Earnings Per Share (EPS)
-0.86
TTM Avg
-2.70
3Y Avg
-2.81
5Y Avg
-3.40
Market Cap
$2.87B
Earnings Per Share (EPS)
0.21
TTM Avg
-0.59
3Y Avg
-0.72
5Y Avg
-0.48
Market Cap
$2.87B
Earnings Per Share (EPS)
3.86
TTM Avg
3.33
3Y Avg
1.17
5Y Avg
0.32
Market Cap
$2.51B
Earnings Per Share (EPS)
-1.04
TTM Avg
-1.56
3Y Avg
-1.52
5Y Avg
-1.27
Market Cap
$2.88B
Earnings Per Share (EPS)
-3.33
TTM Avg
-3.42
3Y Avg
-3.51
5Y Avg
-3.03
Market Cap
$2.43B
Earnings Per Share (EPS)
-6.60
TTM Avg
-4.98
3Y Avg
-14.61
5Y Avg
-21.72
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aveanna Healthcare Holdings Inc. (AVAH) | $2.69B | 1.26 | N/A | 0.11 | -0.77 |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.69B | -12.45 | -4.69 | -1.64 | -2.01 |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.64B | N/A | -0.45 | -0.45 | -0.45 |
| Beam Therapeutics Inc. (BEAM)vs › | $2.64B | -0.86 | -2.70 | -2.81 | -3.40 |
| AtriCure, Inc. (ATRC)vs › | $2.87B | 0.21 | -0.59 | -0.72 | -0.48 |
| TransMedics Group, Inc. (TMDX)vs › | $2.87B | 3.86 | 3.33 | 1.17 | 0.32 |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.51B | -1.04 | -1.56 | -1.52 | -1.27 |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.88B | -3.33 | -3.42 | -3.51 | -3.03 |
| Disc Medicine, Inc. (IRON)vs › | $2.43B | -6.60 | -4.98 | -14.61 | -21.72 |
| Clover Health Investments, Corp. (CLOV)vs › | $2.43B | -0.04 | -0.13 | -0.35 | -0.53 |
Trailing EPS (TTM)
$1.26
Forward EPS (Est.)
$0.82
P/E Ratio
9.8
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2026-01-03 | 1.10 |
| 2024-12-28 | -0.06 |
| 2023-12-31 | -0.71 |
| 2022-12-31 | -3.57 |
| 2021-12-31 | -0.63 |
| 2020-12-31 | -0.31 |
| 2019-12-31 | -0.41 |
| 2018-12-31 | -0.26 |
